Putting adoptive T cell therapy on the path to regulatory approval

Date 03 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session New frontiers in immunotherapy (2): New targets and agents beyond checkpoint inhibition
Topics Bioethics, Legal, and Economic Issues
Cancer Immunology and Immunotherapy
Translational Research
Presenter Anthoni Ribas